4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Quantum BioPharma Ltd. (QNTM) operates in the Biotechnology industry and is headquartered in Toronto, Canada. Its market capitalization is roughly $19 million. In the fiscal year ended 2025-12-31, QNTM reported $0M in revenue and ($26M) in net income.
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($15M) | ($16M) | ($20M) | ($27M) | — |
| Net Income | ($26M) | ($14M) | ($18M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($2M) | ($5M) | ($5M) | ($3M) | — |
| Net Income | ($14M) | ($3M) | ($5M) | ($9M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $11M | $17M | $18M | $38M | — |
| Total Liabilities | $6M | $7M | $5M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QNTM viewer.
About TickerBase · Data methodology & sources